 |
|
Study shows PET can measure effectiveness of novel breast cancer treatment
July 02, 2009Study in mice holds potential for people diagnosed with cancer, according to study
RESTON, Va.-A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Researchers successfully used PET and a specially-developed radioactive compound to image HER2-a protein often associated with aggressive breast cancer-in breast cancer cells before and after treatment aimed at decreasing HER2 expression. This molecular imaging methodology could facilitate development of new targeted therapies not only for breast cancer, but also for certain types of ovarian, prostate, and lung cancers that may be aggravated due to HER2.
"Obtaining an accurate assessment of the HER2 expression levels in breast cancer tumors is absolutely essential to know whether treatment aimed at reduction of the protein levels in tumor cells is effective," said Jacek Capala, senior author of the study and investigator for the radiation oncology branch of the National Cancer Institute, National Institutes of Health, Bethesda, Md. "Our study indicates that PET could be a powerful tool both to identify patients who might benefit from targeted molecular therapies and to manage their care by measuring response to treatment. As research into HER2 therapies continues, similar techniques could be developed for other cancers overexpressing different proteins."
Much new research has been focused on developing therapies targeted to HER2. This protein is overexpressed in approximately 20 percent of breast cancers and also in some ovarian, prostate and lung cancers. Tumors that have an overabundance of HER2 protein are more aggressive and more likely to recur than tumors that do not overexpress the protein.
The imaging technique developed in the study represents a breakthrough in measuring HER2 expression. The conventional method requires biopsies of tumors that have been removed from the body; however, these samples may not represent the overall characteristics of the tumor and may not accurately estimate HER2 expression. In addition, there are currently no means to evaluate how long a therapeutic agent takes to affect the targeted tumors and how long the effects last.
In the study, researchers attached the radioactive nuclide flourine-18 to an HER2-binding variant of a small protein known as an Affibody molecule. PET scans can detect the Affibody compound and allow researchers to visualize breast cancer tumors with HER2 protein in mice. These molecules can also be engineered to specifically bind to other targets for cancer diagnosis and therapy.
The researchers implanted human breast cancer cells-expressing either very high or high levels of HER2-under the skin of mice to show that this method of imaging can be used to monitor changes in HER2 expression after treatment. Researchers then intravenously injected the HER2-targeting Affibody compound and performed PET imaging three to five weeks after tumors had formed. Four doses of the drug 17-DMAG were administered, which decreases HER2 expression, spaced 12 hours apart. PET scans were performed before the treatment and after each dose.
The researchers found that HER2 expression was reduced by 71 percent in mice bearing tumors with very high levels of HER2 protein and by 33 percent in mice bearing tumors with high levels of the protein, compared to the levels measured before treatment and to tumors that did not receive the treatment. Researchers confirmed their data using established laboratory techniques to determine the concentrations of HER2 proteins in the same tumors after they were removed from the mice.
Society of Nuclear Medicine
Much new research has been focused on developing therapies targeted to HER2. This protein is overexpressed in approximately 20 percent of breast cancers and also in some ovarian, prostate and lung cancers. Tumors that have an overabundance of HER2 protein are more aggressive and more likely to recur than tumors that do not overexpress the protein.
The imaging technique developed in the study represents a breakthrough in measuring HER2 expression. The conventional method requires biopsies of tumors that have been removed from the body; however, these samples may not represent the overall characteristics of the tumor and may not accurately estimate HER2 expression. In addition, there are currently no means to evaluate how long a therapeutic agent takes to affect the targeted tumors and how long the effects last.
In the study, researchers attached the radioactive nuclide flourine-18 to an HER2-binding variant of a small protein known as an Affibody molecule. PET scans can detect the Affibody compound and allow researchers to visualize breast cancer tumors with HER2 protein in mice. These molecules can also be engineered to specifically bind to other targets for cancer diagnosis and therapy.
The researchers implanted human breast cancer cells-expressing either very high or high levels of HER2-under the skin of mice to show that this method of imaging can be used to monitor changes in HER2 expression after treatment. Researchers then intravenously injected the HER2-targeting Affibody compound and performed PET imaging three to five weeks after tumors had formed. Four doses of the drug 17-DMAG were administered, which decreases HER2 expression, spaced 12 hours apart. PET scans were performed before the treatment and after each dose.
The researchers found that HER2 expression was reduced by 71 percent in mice bearing tumors with very high levels of HER2 protein and by 33 percent in mice bearing tumors with high levels of the protein, compared to the levels measured before treatment and to tumors that did not receive the treatment. Researchers confirmed their data using established laboratory techniques to determine the concentrations of HER2 proteins in the same tumors after they were removed from the mice.
Society of Nuclear Medicine
Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?
The epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) are involved in the carcinogenesis of many malignancies.
Breast cancer etiology may vary by subtype
Women's reproductive and lifestyle characteristics can be linked to different invasive breast cancer subtypes. Data on 2544 breast cancer cases, presented in the open access journal Breast Cancer Research, suggests that traditional risk factors for development of the condition are associated with different kinds of tumor.
Protein predicts development of invasive breast cancer in women with DCIS, Penn study shows
Women with ductal carcinoma in situ (DCIS) who exhibit an overexpression of the protein HER2/neu have a six-fold increase in risk of invasive breast cancer.
More Her2 Expression Current Events and Her2 Expression News Articles
 |
Hermle Leyton Table Clock with Skeleton Movement by HERMLE Base made of mahogany with burlwood applications, piano finish. Mechanical skeleton movement, 14 days power reserve. One strike on bell per hour. Protective glass dome. 14 x 8 x 8 (inches) |
 |
Dr Scholl's For Her Sole Expressions Insole, Women's 6-10, 3-Pair Packages (Pack of 2) by Dr Scholl's Ideal for all women's shoes, the Dr. Scholl's For Her Sole Expressions Insole comes in a 3-Pack and provides soft cushioning for discreet or fashionable comfort. The soft foam absorbs shock in the heel and cushions the sensitive ball of the foot area. The slim design fits comfortably in most women's shoes without crowding the toes. The insole stays in place with an adhesive strip until removal is desired. Offering the right shade for the right occasion, this set of insoles includes 2 pairs in basic colors to match most shoes, and 1 pair in a fun and fashionable print to add flair to favorite footwear. Works well with open and closed style shoes, including sandals, slides, slingbacks, strappy dress shoes, pumps, loafers, and boots. Made in China. |
|
Particles, and noun-supporting words and expressions (Her Intermediate Japanese reading aids, v. 2) by Yoko Matsuoka McClain (Author) | |
 |
Paterson Glass Wall Clock by Hermle High quality mineral glass. Arabic numerals. Chrome finished pendulum. Quartz, battery operated movement. 24 x 10 x 4 |
 |
For your love, an expression / message of love. A gift of Nancy Gong's Art Glass Blessing, hand cast and carved kiwi green glass; freestanding; calligraphy translates to "Love", share your thoughts with him or her, wife, husband, girlfriend, boyfriend, or someone special to celebrate every day or a Birthday, Wedding, Anniversary or Special occasion gift. Also available in emerald green, sapphire blue, opal black, bronze, yellow and deep amethyst. by Nancy Gong, Glass Artist This Art Glass Blessing has been designed by glass artist Nancy Gong, The Oriental Design celebrates the Chinese culture. The calligraphic design - a Chinese way of thinking, comes from the tradition of hanging hollow brass Chinese characters in the home or business to remind people of the good things in life. This blessing with the character "LOVE" is a beautiful meaningful personal gift, depicted in a bright, earthy, kiwi green, that allows you to express your feelings in a unique and timeless way. |
|
|
Dr Scholl's For Her Sole Expressions Insole, Women's 6-10, 3-Pair Packages (Pack of 2) by Dr Scholl's Ideal for all women's shoes, the Dr. Scholl's For Her Sole Expressions Insole comes in a 3-Pack and provides soft cushioning for discreet or fashionable comfort. The soft foam absorbs shock in the heel and cushions the sensitive ball of the foot area. The slim design fits comfortably in most women's shoes without crowding the toes. The insole stays in place with an adhesive strip until removal is desired. Offering the right shade for the right occasion, this set of insoles includes 2 pairs in basic colors to match most shoes, and 1 pair in a fun and fashionable print to add flair to favorite footwear. Works well with open and closed style shoes, including sandals, slides, slingbacks, strappy dress shoes, pumps, loafers, and boots. Made in China. |
| © 2009 BrightSurf.com |